X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32334) 32334
Book Review (3114) 3114
Publication (1159) 1159
Newsletter (384) 384
Conference Proceeding (54) 54
Magazine Article (28) 28
Book Chapter (18) 18
Dissertation (15) 15
Newspaper Article (15) 15
Book / eBook (2) 2
Reference (2) 2
Government Document (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (29711) 29711
humans (28090) 28090
fluorouracil - administration & dosage (21329) 21329
female (19666) 19666
middle aged (17067) 17067
male (16344) 16344
antineoplastic combined chemotherapy protocols - therapeutic use (15104) 15104
aged (14821) 14821
oncology (14305) 14305
adult (12497) 12497
chemotherapy (9556) 9556
fluorouracil (9232) 9232
cancer (7411) 7411
treatment outcome (6652) 6652
5-fluorouracil (6026) 6026
cisplatin - administration & dosage (5596) 5596
antineoplastic combined chemotherapy protocols - adverse effects (5536) 5536
fluorouracil - therapeutic use (5105) 5105
fluorouracil - adverse effects (4891) 4891
combined modality therapy (4819) 4819
leucovorin - administration & dosage (4727) 4727
antineoplastic combined chemotherapy protocols - administration & dosage (4523) 4523
colorectal neoplasms - drug therapy (4447) 4447
drug administration schedule (4404) 4404
animals (4130) 4130
breast neoplasms - drug therapy (3937) 3937
neoplasm staging (3881) 3881
aged, 80 and over (3691) 3691
colorectal cancer (3636) 3636
deoxycytidine - analogs & derivatives (3572) 3572
chemotherapy, adjuvant (3465) 3465
survival rate (3423) 3423
adenocarcinoma - drug therapy (3380) 3380
capecitabine (3332) 3332
prognosis (3277) 3277
disease-free survival (3245) 3245
surgery (3205) 3205
leucovorin (3159) 3159
fluorouracil - analogs & derivatives (3153) 3153
carcinoma (3139) 3139
organoplatinum compounds - administration & dosage (3120) 3120
therapy (3049) 3049
colorectal neoplasms - pathology (2979) 2979
cyclophosphamide - administration & dosage (2972) 2972
care and treatment (2913) 2913
deoxycytidine - administration & dosage (2818) 2818
antimetabolites, antineoplastic - administration & dosage (2799) 2799
pharmacology & pharmacy (2788) 2788
retrospective studies (2787) 2787
oxaliplatin (2738) 2738
survival analysis (2724) 2724
cisplatin (2629) 2629
follow-up studies (2606) 2606
stomach neoplasms - drug therapy (2563) 2563
camptothecin - analogs & derivatives (2549) 2549
liver neoplasms - secondary (2507) 2507
radiotherapy (2473) 2473
antineoplastic agents - administration & dosage (2466) 2466
liver neoplasms - drug therapy (2465) 2465
methotrexate - administration & dosage (2423) 2423
neoplasm metastasis (2401) 2401
abridged index medicus (2396) 2396
medicine & public health (2372) 2372
mice (2341) 2341
survival (2329) 2329
doxorubicin - administration & dosage (2292) 2292
trial (2272) 2272
research (2255) 2255
carcinoma, squamous cell - drug therapy (2121) 2121
camptothecin - administration & dosage (2114) 2114
time factors (2114) 2114
metastasis (2035) 2035
prospective studies (1965) 1965
fluorouracil - pharmacology (1948) 1948
infusions, intravenous (1943) 1943
antineoplastic agents - therapeutic use (1900) 1900
colonic neoplasms - drug therapy (1900) 1900
dose-response relationship, drug (1858) 1858
breast neoplasms - pathology (1857) 1857
analysis (1800) 1800
irinotecan (1785) 1785
breast cancer (1766) 1766
antimetabolites, antineoplastic - therapeutic use (1672) 1672
drug therapy, combination (1655) 1655
lymphatic metastasis (1587) 1587
bevacizumab (1579) 1579
drug therapy (1572) 1572
stomach neoplasms - pathology (1439) 1439
combination (1438) 1438
administration, oral (1436) 1436
adenocarcinoma - pathology (1432) 1432
neoadjuvant therapy (1415) 1415
clinical trials as topic (1402) 1402
health aspects (1397) 1397
tumors (1386) 1386
infusions, intra-arterial (1382) 1382
randomized-trial (1372) 1372
colorectal-cancer (1369) 1369
toxicity (1346) 1346
phase-ii (1337) 1337
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27730) 27730
Japanese (2839) 2839
German (510) 510
French (477) 477
Chinese (420) 420
Russian (307) 307
Italian (139) 139
Spanish (105) 105
Polish (63) 63
Hungarian (29) 29
Portuguese (24) 24
Czech (17) 17
Korean (16) 16
Dutch (14) 14
Norwegian (12) 12
Romanian (11) 11
Danish (10) 10
Hebrew (10) 10
Slovak (8) 8
Ukrainian (8) 8
Bulgarian (7) 7
Swedish (6) 6
Croatian (5) 5
Lithuanian (5) 5
Serbian (4) 4
Turkish (3) 3
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 4/2008, Volume 100, Issue 8, pp. 542 - 551
Background Among breast cancer patients, nonresponse to initial neoadjuvant chemotherapy is associated with unfavorable outcome. We compared the response of... 
THERAPY | GEPARDUO | ONCOLOGY | PROGNOSIS | CARCINOMA | CHEMOTHERAPY | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Vinblastine - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Breast Neoplasms - chemistry | Carcinoma, Ductal, Breast - drug therapy | Fluorouracil - administration & dosage | Vinblastine - analogs & derivatives | Mastectomy, Segmental | Adult | Female | Breast Neoplasms - diagnostic imaging | Chemotherapy, Adjuvant | Doxorubicin - administration & dosage | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Biomarkers, Tumor - analysis | Deoxycytidine - administration & dosage | Ultrasonography, Mammary | Treatment Outcome | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Aged | Carcinoma, Lobular - drug therapy | Patient Compliance | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Germany | Chemotherapy | Breast cancer | Drug therapy | Comparative analysis | Health aspects | Cancer | Side effects | Toxicity | Clinical outcomes | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 869 - 878
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 499 - 508
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 1/2008, Volume 100, Issue 2, pp. 121 - 133
Background Docetaxel is more effective than doxorubicin for patients with advanced breast cancer. The Breast International Group 02-98 randomized trial tested... 
CANCER PATIENTS | 1ST-LINE TREATMENT | PHASE-II TRIAL | THERAPY | EPIRUBICIN | ONCOLOGY | DOXORUBICIN PLUS CYCLOPHOSPHAMIDE | METHOTREXATE | COMBINATION CHEMOTHERAPY | FLUOROURACIL | CMF | Immunohistochemistry | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Mastectomy - methods | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Tamoxifen - administration & dosage | Receptors, Progesterone - analysis | Antineoplastic Agents, Phytogenic - administration & dosage | Breast Neoplasms - chemistry | Fluorouracil - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Odds Ratio | Adenocarcinoma - chemistry | Doxorubicin - administration & dosage | Drug Administration Schedule | Estrogen Receptor Modulators - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Lymphatic Metastasis | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Methotrexate - administration & dosage | Aged | Adenocarcinoma - surgery | Breast cancer | Dosage and administration | Drug therapy | Comparative analysis | Doxorubicin | Docetaxel | Clinical trials | Comparative studies | Chemotherapy | Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2013, Volume 31, Issue 7, pp. 860 - 867
Journal Article
Cancer, ISSN 0008-543X, 10/2015, Volume 121, Issue 20, pp. 3639 - 3648
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 23, pp. 3786 - 3793
Purpose Data concerning the prevalence of and outcomes related to thromboembolic events (TEs) in patients with advanced gastroesophageal cancer who are... 
CISPLATIN-BASED CHEMOTHERAPY | PHASE-III TRIAL | BREAST-CANCER | FLUOROURACIL PLUS OXALIPLATIN | ONCOLOGY | ADVANCED ESOPHAGOGASTRIC CANCER | TESTICULAR CANCER | VASCULAR EVENTS | CENTRAL VENOUS CATHETERS | 1ST-LINE THERAPY | METASTATIC COLORECTAL-CANCER | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Anticoagulants - administration & dosage | Thromboembolism - chemically induced | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Epirubicin - administration & dosage | Thromboembolism - epidemiology | Warfarin - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Incidence | Esophageal Neoplasms - complications | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Odds Ratio | Catheterization, Central Venous - adverse effects | Stomach Neoplasms - complications | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Esophagogastric Junction - pathology | Thromboembolism - etiology | Stomach Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Cisplatin - adverse effects | Aged | Esophageal Neoplasms - drug therapy | United Kingdom - epidemiology | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 9, pp. 853 - 860
Summary Background Fluorouracil and folinic acid with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are widely used as first-line or second-line... 
Hematology, Oncology and Palliative Medicine | TRIAL | CAPECITABINE | 1ST-LINE TREATMENT | INFUSIONAL FLUOROURACIL/LEUCOVORIN | THERAPY | ONCOLOGY | 5-FLUOROURACIL/FOLINIC ACID | FLUOROPYRIMIDINES | OXALIPLATIN | III NONINFERIORITY | FAILURE | Prodrugs - administration & dosage | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Fluorouracil - analogs & derivatives | Tegafur - adverse effects | Kaplan-Meier Estimate | Oxonic Acid - administration & dosage | Adenocarcinoma - drug therapy | Oxonic Acid - adverse effects | Disease-Free Survival | Prodrugs - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Drug Combinations | Adenocarcinoma - mortality | Medical colleges | Chemotherapy | Oncology, Experimental | Colorectal cancer | Leucovorin | Research | Metastasis | Cancer | Fluorouracil | Analysis | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2014, Volume 32, Issue 21, pp. 2240 - 2247
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9707, pp. 2055 - 2063
Summary Background Tamoxifen is standard adjuvant treatment for postmenopausal women with hormone-receptor-positive breast cancer. We assessed the benefit of... 
Internal Medicine | CELLS | WOMEN | MEDICINE, GENERAL & INTERNAL | THERAPY | CYCLOPHOSPHAMIDE | METHOTREXATE | ANTAGONISM | CARCINOMA | FLUOROURACIL CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Lymph Nodes - pathology | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Alkylating - administration & dosage | Tamoxifen - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Receptors, Progesterone - analysis | Fluorouracil - administration & dosage | Postmenopause | Adult | Female | Chemotherapy, Adjuvant | Doxorubicin - administration & dosage | Antineoplastic Agents, Hormonal - administration & dosage | Lymphatic Metastasis | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Adenocarcinoma - mortality | Adjuvant treatment | Breast cancer | Dosage and administration | Research | Drug therapy | Tamoxifen | Health aspects | Cancer | Heart failure | Chemotherapy | Womens health | Mortality | Clinical trials | Mammography | Radiation therapy | Cancer therapies | Tumors | Toxicity | Leukemia | Congestive heart failure | Doxorubicin | Subgroups | Rank tests | Randomization | Motivation | Registration | Mastectomy | Thromboembolism | Neutropenia | Review boards | Regression analysis | Patients | Survival | Post-menopause | Stomatitis | Cyclophosphamide | Anthracycline | Breast | Index Medicus | Abridged Index Medicus
Journal Article